Belkyra™

Belkyra, also known as Kybella in the United States, is a non-surgical injectable treatment used for the reduction of submental fat, commonly referred to as a "double chin." It is an FDA-approved prescription medicine that contains deoxycholic acid, a naturally occurring substance in the body that aids in the breakdown and absorption of dietary fat.

When injected into the fat beneath the chin, Belkyra/Kybella destroys fat cells, leading to a noticeable reduction in the appearance of a double chin. The body naturally processes and eliminates the damaged fat cells, resulting in a more defined and sculpted jawline over time.

IMG_0021.jpeg
IMG_0037.jpg
IMG_0099.jpeg

  • Belkyra is an injectable treatment used to reduce submental fat, or the fat under the chin.

  • Belkyra/Kybella destroys fat cells when injected into the submental area, leading to a reduction in the appearance of a double chin. The body naturally eliminates the damaged fat cells over time.

  • The primary use is to treat submental fat or a double chin, but it may also be used for off-label purposes in other areas with localized fat deposits.

  • The results of Belkyra treatments can be long-lasting, as the destroyed fat cells are typically not replaced. However, maintaining a stable weight and a healthy lifestyle is essential to prevent the accumulation of new fat in the treated area.

  • Belkyra is an FDA-approved treatment and is generally considered safe when administered by a qualified healthcare provider.

  • Ideal candidates for Belkyra are individuals with moderate to severe submental fat who want to improve their chin profile. It's important to consult with a healthcare provider to determine if Belkyra is suitable for you.

  • The number of treatments required can vary from person to person. Most patients receive a series of treatments, typically spaced 4 to 6 weeks apart. Your healthcare provider will assess your progress and determine the number of treatments needed.

  • The number of treatments required can vary from person to person. Most patients receive a series of treatments, typically spaced 4 to 6 weeks apart. Your healthcare provider will assess your progress and determine the number of treatments needed.

  • Common side effects of Belkyra include swelling, bruising, pain, numbness, and redness at the injection site. Serious side effects are rare but can include nerve injury or trouble swallowing.

  • Cost is $699 per treatment vial, multiple vials may be required at each session. Please book a consultation.

Subscribe

Subscribe